Safety of anagliptin/metformin combination tablets evaluated by non-inferiority between pre- and post-serum lactic acid levels in Japanese patients with type 2 diabetes and moderate renal impairment (AMELIO STUDY).
- DOI
- 10.1111/jdi.70253
- Published
- 2026 Apr
- Container
- Journal of diabetes investigation
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/jdi.70253,
title = {Safety of anagliptin/metformin combination tablets evaluated by non-inferiority between pre- and post-serum lactic acid levels in Japanese patients with type 2 diabetes and moderate renal impairment (AMELIO STUDY).},
author = {Kajio H and Bouchi R and Komatsu M and Yamazaki M and Takarabe D and Okamoto M and Tanaka T and Kitazawa T and Katsuyama H and Mori Y and Noda M},
year = {2026},
journal = {Journal of diabetes investigation},
doi = {10.1111/jdi.70253},
url = {https://doi.org/10.1111/jdi.70253}
}RIS
TY - JOUR TI - Safety of anagliptin/metformin combination tablets evaluated by non-inferiority between pre- and post-serum lactic acid levels in Japanese patients with type 2 diabetes and moderate renal impairment (AMELIO STUDY). AU - Kajio H AU - Bouchi R AU - Komatsu M AU - Yamazaki M AU - Takarabe D AU - Okamoto M AU - Tanaka T AU - Kitazawa T AU - Katsuyama H AU - Mori Y AU - Noda M PY - 2026 JO - Journal of diabetes investigation DO - 10.1111/jdi.70253 UR - https://doi.org/10.1111/jdi.70253 ER -
APA
H, K., R, B., M, K., M, Y., D, T., M, O., T, T., T, K., H, K., Y, M., & M, N. (2026). Safety of anagliptin/metformin combination tablets evaluated by non-inferiority between pre- and post-serum lactic acid levels in Japanese patients with type 2 diabetes and moderate renal impairment (AMELIO STUDY).. Journal of diabetes investigation. https://doi.org/10.1111/jdi.70253
Source records
- pubmed · retrieved 2026-09-27T16:27:20.765Z